Verition Fund Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.11M Sell
23,527
-790
-3% -$37.3K ﹤0.01% 1791
2025
Q1
$950K Buy
+24,317
New +$950K ﹤0.01% 1650